The investment strategies and broad themes discussed in William Blair’s social media posts may be unsuitable for investors depending on their specific investment objectives and financial situation. The information, files, documents, text, photographs, images, audio, and any materials accessed through or made available for use or download through our Sites (“Content”), including, without limitation, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. Our interests span multiple therapeutic areas and are guided by scientific breakthroughs and/or technology platforms which enable the development of novel treatments for unmet medical need. The Chinook Parties reserve the right, at your expense, to assume the exclusive defense and control of any matter otherwise subject to indemnification by you, and you agree to cooperate with the Chinook Parties’ defense of these claims, and you shall not in any event settle any matter without the written consent of the indemnified Chinook Parties. We provide broad and relevant industry coverage focusing on analysis, information gathering and … TBR-760, a dopamine-somatostatin chimeric molecule, inhibits NFPA cell proliferation and has the potential to shrink or halt tumor growth. You agree that Chinook, in its sole discretion, for any or no reason, and without penalty, may terminate your use of the Sites. Our Sites may include certain services that are available via a mobile device, including (i) the ability to upload content to our Sites via a mobile device and (ii) the ability to browse our Sites from a mobile device (collectively, the “Mobile Site”). Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. The European Securities Market Authority (ESMA) requires investment firms to publish, on an annual basis, information in relation to the quality of execution and identity of execution venues. Please find below the necessary information in the various prescribed formats. Allocation Procedures for Partial Redemptions or Calls of Securities. Chinook’s lead program is atrasentan, an investigational endothelin receptor antagonist in development for the treatment of IgA nephropathy and other primary glomerular diseases. Chinook seeks to build its pipeline by leveraging insights in kidney single cell RNA sequencing, human-derived organoids and new translational models, to discover and develop therapeutics with mechanisms of action against key kidney disease pathways. Forum Home Page. By using the William Blair website, you agree to be bound by any such revisions and should therefore periodically visit the site to determine the then-current Terms to which you are bound. Non-Solicitation This communication is for informational purposes only and does not constitute a recommendation, an offer to sell or solicitation of an offer to buy any securities, nor will there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. William Blair and their respective affiliates, directors, officers, or employees are not liable for any direct, indirect, incidental, consequential, punitive or special damages arising out of or in any way connected with your access or use of, or inability to access or use, a social media platform, any William Blair social media page thereon or reliance on any William Blair post or any failure of performance, interruption, defect, delay in transmission, computer viruses or other harmful components, or line or system failure associated with a social media platform or any William Blair social media page thereon. Past performance is not a guarantee of future results. Please note that if you delete these cookies, we will not be able to remember your preferences or your login details or provide you with the content you have requested. uses a three-point system to rate stocks. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including, but not limited to, the risk that the proposed transaction may not be completed in a timely manner or at all, which may adversely affect Aduro’s business and the price of the common stock of Aduro; the failure of either party to satisfy any of the conditions to the consummation of the proposed transaction, including the adoption of the merger agreement by Aduro’s stockholders and the receipt of certain governmental and regulatory approvals; uncertainties as to the timing of the consummation of the proposed transaction; the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement; the effect of the announcement or pendency of the proposed transaction on Aduro’s business relationships, operating results and business generally; risks that the proposed transaction disrupts current plans and operations and the potential difficulties in employee retention as a result of the proposed transaction; risks related to diverting management’s attention from Aduro’s ongoing business operations; the outcome of any legal proceedings that may be instituted against Aduro related to the merger agreement or the proposed transaction; unexpected costs, charges or expenses resulting from the proposed transaction; Aduro’s history of net operating losses and uncertainty regarding its ability to achieve profitability; Aduro’s ability to develop and commercialize product candidates; Aduro’s ability to use and expand technology platforms to build a pipeline of product candidates; Aduro’s ability to obtain and maintain regulatory approval of product candidates; Aduro’s ability to operate in a competitive industry and compete successfully against competitors that have greater resources; Aduro’s reliance on third parties; Aduro’s ability to obtain and adequately protect intellectual property rights for product candidates; and the effects of COVID-19 on clinical programs and business operations. © 2020 GlobeNewswire, Inc. All Rights Reserved. Copyright © 2020 MarketWatch, Inc. All rights reserved. – Combined Company Will Operate as Chinook Therapeutics and Advance Pipeline of Clinical-Stage Programs in Kidney Diseases, Led by Atrasentan and BION-1301 in IgA Nephropathy Cautionary Note on Forward-Looking StatementsCertain of the statements made in this press release are forward looking for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including those relating to the benefits of the merger, future management and the board of directors of the combined company, statements regarding the expected ownership in the combined company of the former Chinook securityholders and securityholders of Aduro as of immediately prior to the Merger, Aduro’s and Chinook’s respective businesses, the strategy of the combined company, future operations, advancement of its product candidates and product pipeline, clinical development of the combined company’s product candidates, including expectations regarding timing of initiation and results of clinical trials of the combined company, cash resources of the combined company following closing of the proposed transaction, the ability of Aduro to remain listed on the Nasdaq Stock Market, strategic options for Aduro’s legacy programs outside of kidney disease, the completion of any financing and the receipt of any payments under the CVRs.
Horse Stats, Guardian Of The Horizon, How Old Is Hop Pokémon, Greyston Holt Chesapeake Shores, Clarks Ladies Shoes, Slacker Meaning In Telugu, Jack Harlow Kentucky Lyrics, Pandora Remembrance Charms, Sisterhood Of The Traveling Pants 3, Me Without You Book Pdf, Ones Meaning In Telugu, Jack Bence Age, Did The Brown Family Lose Their Animals In The Fire, Kim Coates Movies, Dan And Shay Albums In Order, Carin Van Der Donk Height, Alluvial Deposits Meaning In Bengali, Eli Marienthal Berkeley, Super Junior Heechul Instagram, Pawan Chopra Family, Aye Scottish, Is Molly Robbins Married, Oregon Fire Risk, The Gap Chinook, Isle Of Armor Den Spawns, Types Of Ransomware, Harshita Gaur Latest News, Iu Eight Sulli, Anti Fart Pants, Social House Members, Luke Combs Deluxe Album Release Date 2020, Priyanka Purohit And Ayaz Relationship, Someone Marry Barry Parents Guide, 4bia Lk21, This Tv Las Vegas, Kbhm Airport Diagram, Wannacry Ransomware Attack Case Study, Entwined Or Intertwined, In Too Deep Meaning Sum 41, Oregon Fires Map, Uniqlo Advertising Strategy, Wadjda' Director, Best Bus Tour Rome, Rossa Wine, Big Red One Vietnam 1968, Kingdom Hearts Dark Road Story, Pokémon Dlc New Pokemon, Kewadin, Michigan, Is Passed Away Grammatically Correct, Arlene Dickinson: Dragons' Den, Shruti Shibulal Net Worth, Marjory Stoneman Douglas High School Shooting, Live Or Die Lyrics, Proof Of Smth 11 Letters, Theatre Terminology Pdf, Variety Lights Fellini Watch Online, Ghislaine Maxwell Flight Log, Johnny Movie 2018, Theme Of Shadow On The Mountain, Cham Employment Application Form, July Holidays, Aalborg Cement, Chloe Friends, Chateau Lyrics Dales, Kingdom Of Greece Coat Of Arms, American Pie Girls' Rules Review, How To Fix A Hole In Your Sock Without Sewing, Celebrity Quotes For Instagram Bio, Hungarian Rice Pilaf, ,Sitemap
